Research
Adherence
Long-term pharmacotherapy for obesity is consistent with the consensus that obesity is a chronic disease requiring long-term management, as short-term interventions fail to sustain weight loss.
Treat obesity as a chronic condition, not a short-term goal. Just like managing blood pressure, it requires ongoing management. This mindset shift is crucial for deciding whether to use long-term pharmacotherapy.
GoodSupportsHIGH confidence
The long-term use of medications in the management of obesity is consistent with the current consensus that obesity responds poorly to short-term interventions.
Why this rating
Based on a broad consensus of scientific information and reviews.
Source
Long-term Pharmacotherapy in the Management of Obesity
JAMA · 1996
DOI 10.1001/jama.1996.03540230057036
narrative_reviewCited 174×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →